NTLA
Intellia Therapeutics Inc
13.10$
+3.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.6% | +10.4% | -4.8% | +23.7% | -8.9% | +12.0% | +2.8% | -3.5% | +6.4% | +32.4% | +6.6% | -4.5% | +3.0% | +18.1% | +25.9% | +36.6% | -70.3% | -2.3% | +1.6% | +10.0% | +78.4% | -12.5% | +24.7% | -5.4% | +2.3% | -7.1% | +7.8% | -11.8% | -116.0% | – | -76.0% | +31.0% | +41.3% | +29.2% | -14.3% | -3.3% | +67.0% | -34.6% | -49.1% | – | |
| – | +44.1% | +18.5% | +15.9% | +12.3% | +21.1% | +6.2% | +4.3% | -1.0% | -14.3% | +19.0% | +7.4% | +8.1% | +15.3% | +9.2% | +9.0% | +5.3% | -3.8% | +2.7% | +49.9% | +2.7% | +17.6% | +87.0% | -32.2% | +7.2% | +3.5% | -2.9% | +18.7% | -98.0% | +7.7% | +1.9% | +3.5% | +4,100.6% | +7.1% | – | – | -2.0% | -92.4% | -63.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -145.2% | – | -83.5% | -2,396.1% | – | – | -498.7% | – | – | -24.4% | -40.4% | – | |
| – | +44.1% | +18.5% | +15.9% | +12.3% | +21.1% | +6.2% | +4.3% | -1.0% | -14.3% | +19.0% | +7.4% | +8.1% | +15.3% | +9.2% | +9.0% | +5.3% | -3.8% | +2.7% | +49.9% | +2.7% | +17.6% | +87.0% | -32.2% | +7.2% | +3.5% | -2.9% | +18.7% | -1.4% | -4.1% | +0.3% | +2.1% | +10.5% | -5.3% | -7.2% | -10.5% | -2.4% | -6.4% | -8.9% | +2.3% | – | |
| – | +8.8% | +12.0% | +11.1% | -10.3% | +78.8% | -27.5% | +5.4% | +6.0% | +5.3% | +21.0% | +24.5% | -35.7% | +6.5% | +26.0% | +1.9% | -8.3% | +1.9% | +26.3% | +22.7% | +12.2% | +18.2% | +1.3% | -1.2% | +0.1% | +6.7% | +16.2% | +11.7% | -4.1% | -1.4% | +7.2% | +2.3% | -4.1% | +6.4% | -10.6% | -6.2% | +12.2% | +8.4% | +5.3% | +8.6% | – | |
| – | +30.9% | +16.5% | +14.5% | +5.7% | +35.3% | -4.7% | +4.6% | +0.8% | -9.1% | +19.6% | +12.7% | -6.8% | -75.0% | +26.0% | +1.9% | -8.3% | +1.9% | +26.3% | +22.7% | +12.2% | +18.2% | +1.3% | -1.2% | +0.1% | +6.7% | +16.2% | +11.7% | +359.4% | -3.8% | +3.6% | +2.1% | -68.8% | -27.4% | +323.6% | -68.2% | +6.0% | +149.9% | -2.0% | +6.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -48.4% | -59.1% | -21.0% | +6.3% | -4.1% | +65.4% | +44.1% | -16.3% | +67.0% | +176.7% | +175.3% | +65.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -43.4% | -424.8% | – | – | – | -93.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.